Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-04

Clinical Trial Update: Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dutasteride, finasteride, and placebo in men with androgenetic alopecia completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUTASTERIDE (Dutasteride)
  • FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Androgenetic Alopecia | Phase 3 | Status: COMPLETED | Results posted: 2012-10-04